The Nigerian website "24Hours Naija News" devotes a report to the use of insects such as termites and grasshoppers in the treatment of cancer, diabetes, rheumatoid arthritis or Human Immuno-deficiency Virus (HIV).
The article includes a reference to the research on the use of wasp venom as a strategy to kill cancer cells selectively lead by Ernest Giralt, head of the Design, Synthesis and Structure of Peptides and Proteins Lab at IRB Barcelona.
Link to 24Hours Naija News
Gonzalo Fernández-Miranda, associate researcher at IRB Barcelona, leads this therapeutic project selected by CaixaImpulse to facilitate its development towards the market.
"Saber Vivir" magazine dedicates an article to a study—co-led by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona—on an innovative approach to provide an adenovirus with high specificity against tumour cells.
The article includes Raúl Méndez's comments about the effectiveness of this new strategy to achieve genetically modified viruses that infect only tumor cells, thus preserving healthy tissues: "It would be effective in a large number of tumours".
La Sexta newscast team has covered the research performed by IDIBAPS Biomedical Research Institute and IRB Barcelona scientists on a new strategy to achieve genetically modified viruses that selectively attack tumor cells without affecting healthy tissues.
